University of Bari
Antonio Scilimati graduated cum laude in Chemistry at the University of Bari (Italy). PhD at the University of Wisconsin (USA). Four years as a Qualified Person at MerckSerono plant producing recombinant drugs. Now, he is an Associate Professor at University of Bari, teaching Medicinal Chemistry. In "medicinal science", he uses the theranostic approach to target the cyclooxygenase (COX)-1 as a novel biomarker in oncology and neuroinflammation.
Neurochemistry, Neurology, Neuro-oncology